Carcinoembryonic antigen and recurrent colorectal cancer.
作者信息
Northover J
出版信息
Gut. 1986 Feb;27(2):117-22. doi: 10.1136/gut.27.2.117.
Abstract
摘要
相似文献
1
Carcinoembryonic antigen and recurrent colorectal cancer.癌胚抗原与复发性结直肠癌
Gut. 1986 Feb;27(2):117-22. doi: 10.1136/gut.27.2.117.
2
[Value of CEA in the early diagnosis of colorectal cancer recurrence in the light of second-look results].[从二次探查结果看癌胚抗原在结直肠癌复发早期诊断中的价值]
Minerva Med. 1986 Mar 31;77(13):495-8.
3
[CEA assays in postoperative detection of recurrent colorectal carcinoma (author's transl)].癌胚抗原检测在结直肠癌术后复发检测中的应用（作者译）
Nihon Gan Chiryo Gakkai Shi. 1980 Dec 20;15(7):1137-42.
4
A retrospective and prospective study of serial CEA determinations in the early detection of recurrent colon cancer.一项关于连续测定癌胚抗原（CEA）在复发性结肠癌早期检测中的回顾性和前瞻性研究。
Am J Surg. 1979 Feb;137(2):167-9. doi: 10.1016/0002-9610(79)90137-5.
5
6
[Colorectal cancer recurrence. Early diagnosis by determination of a carcinoembryonic antigen in the serum].
Tidsskr Nor Laegeforen. 1985 Oct 20;105(29):2044-6.
7
Reoperation directed by carcinoembryonic antigen level: the importance of a thorough preoperative evaluation.癌胚抗原水平指导下的再次手术：全面术前评估的重要性
Am J Surg. 1988 Feb;155(2):227-31. doi: 10.1016/s0002-9610(88)80699-8.
8
Preoperative CEA level: a prognostic test in patients with colorectal carcinoma.术前癌胚抗原水平：结直肠癌患者的一项预后检测指标
Am Surg. 1980 Aug;46(8):449-52.
9
Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer.连续癌胚抗原（CEA）检测在结直肠癌术后复发检测中的评估
Cancer. 1976 Dec;38(6):2310-5. doi: 10.1002/1097-0142(197612)38:6<2310::aid-cncr2820380618>3.0.co;2-l.
10
[Significance of carcinoembryonic antigen in the treatment of colorectal cancers].[癌胚抗原在结直肠癌治疗中的意义]
Zentralbl Chir. 1986;111(18):1119-23.
引用本文的文献
1
Blood CEA levels for detecting recurrent colorectal cancer.用于检测复发性结直肠癌的血液癌胚抗原水平。
Cochrane Database Syst Rev. 2015 Dec 10;2015(12):CD011134. doi: 10.1002/14651858.CD011134.pub2.
2
Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?结直肠癌患者术后持续高癌胚抗原——这很重要吗？
Clinics (Sao Paulo). 2009;64(4):287-94. doi: 10.1590/s1807-59322009000400004.
3
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.组织蛋白酶B、组织蛋白酶L、尿激酶型纤溶酶原激活剂、纤溶酶原激活剂抑制剂-1、癌胚抗原和CA 19-9在结直肠癌中的肿瘤标志物效用及预后相关性
BMC Cancer. 2008 Jul 10;8:194. doi: 10.1186/1471-2407-8-194.
4
CAM 17.1--a new diagnostic marker in pancreatic cancer.CAM 17.1——胰腺癌中的一种新诊断标志物。
Br J Cancer. 1996 Dec;74(12):1997-2002. doi: 10.1038/bjc.1996.666.
5
A prospective study of six methods for detection of hepatic colorectal metastases.六种检测肝结肠转移瘤方法的前瞻性研究。
Ann R Coll Surg Engl. 1996 Jan;78(1):27-30.
6
Computerised audit for colorectal cancer.结直肠癌的计算机化审计
Ann R Coll Surg Engl. 1993 Jul;75(4):268-71.
7
The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer.CA-242和癌胚抗原在结直肠癌根治性切除术后监测中的作用。
Br J Cancer. 1994 Sep;70(3):549-53. doi: 10.1038/bjc.1994.343.
8
Development of an ELISA to detect early local relapse of colorectal cancer.用于检测结直肠癌早期局部复发的酶联免疫吸附测定法的开发。
Br J Cancer. 1989 Oct;60(4):533-7. doi: 10.1038/bjc.1989.308.
9
Rectal endosonography for the visualisation of the anastomosis after anterior resection and its relevance to local recurrence.
Int J Colorectal Dis. 1990 Aug;5(3):127-9. doi: 10.1007/BF00300400.
本文引用的文献
1
The rationale of re-resection for recurrent cancer of the colon and rectum.结肠直肠癌复发后再次手术切除的理论依据。
Dis Colon Rectum. 1959 Nov-Dec;2:549-54. doi: 10.1007/BF02617007.
2
The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers.术前血浆癌胚抗原水平在结直肠癌根治性切除术后患者分层中的应用。
Ann Surg. 1980 Dec;192(6):747-51. doi: 10.1097/00000658-198012000-00010.
3
Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen.60次二次探查手术主要由连续癌胚抗原升高所指征。
J Surg Res. 1980 May;28(5):389-94. doi: 10.1016/0022-4804(80)90100-6.
4
The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.复发性结直肠癌中血清癌胚抗原（CEA）水平升高模式的临床意义
Br J Surg. 1980 Jan;67(1):46-8. doi: 10.1002/bjs.1800670114.
5
A retrospective study of serial CEA determinations in the early detection of recurrent colorectal cancer.一项关于连续测定癌胚抗原（CEA）在复发性结直肠癌早期检测中的回顾性研究。
Dis Colon Rectum. 1981 Nov-Dec;24(8):618-21. doi: 10.1007/BF02605759.
6
The usefulness and limitations of CEA assay in the management of colorectal cancer.癌胚抗原检测在结直肠癌管理中的作用及局限性。
Jpn J Surg. 1981 Jan;11(1):33-8. doi: 10.1007/BF02468817.
7
CEA testing in colorectal cancer.结直肠癌中的癌胚抗原检测
Med J Aust. 1981 Aug 22;2(4):201. doi: 10.5694/j.1326-5377.1981.tb100898.x.
8
Second-look laparotomy based on CEA elevations in colorectal cancer.
Cancer. 1981 May 1;47(9):2119-25. doi: 10.1002/1097-0142(19810501)47:9<2119::aid-cncr2820470903>3.0.co;2-7.
9
Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.癌胚抗原（CEA）在结肠直肠癌患者中的临床意义。
Acta Chir Scand. 1982;148(2):189-93.
10
Plasma CEA in the post-surgical monitoring of colorectal carcinoma.血浆癌胚抗原在结直肠癌术后监测中的应用
Br J Cancer. 1982 Sep;46(3):323-30. doi: 10.1038/bjc.1982.207.
Zotero 插件